Six 20 Minutes Webcasts
ACR POINT-OF-CARE TESTING: A GAME CHANGER FOR DETECTING AND MANAGING KIDNEY DISEASE
Watch the episodes
Prevention and Treatment CKD: Case Study from the Cardiometabolic Institute
Kidney Disease? Case Study from a Diabetes and Lipids Outpatient Clinic
Albumin-to-Creatinine Ratio (ACR) point-of-care testing: successful implementation in the GP office
Impact of ACR POC testing on the diagnosis and management of diabetic kidney disease
Should you screen for kidney damage?
What do the guidelines say?
ACR – The window to early kidney disease
Chronic kidney disease is a common and often silent condition – up to one in ten adults could be affected in Europe, Canada and Israel, yet only one-third of these will have had a diagnosis1. Early detection can slow disease progression or even prevent it altogether2 — which is why testing in at-risk groups is so important.
Join this livestream series of 20 minutes each to learn how early detection can slow disease progression or even prevent it altogether.
Our international speakers will discuss the role of rapid diagnostics in disease prevention, with point-of-care testing such as an Albumin Creatinine Ratio (ACR) assay, enabling healthcare providers to detect, and treat, kidney disease in minutes.
Learn more about current guidelines and kidney disease prevention and management.
Series of six livestream events covering:
- Importance of regular testing for early detection and monitoring in high-risk patients
- Importance of ACR testing beside the determination of eGFR
- Latest guidance on disease prevention and management
- Case studies
Sundström J, Bodegard J, Bollmann A et al. CaReMe CKD study: Prevalence, outcomes, and cost of CKD in a contemporary population of 2.4 million patients from 11 countries. The Lancet Regional Health – Europe 2022;00: 100438
The International Society of Nephrology (ISN). Chronic Kidney Disease: HYPERLINK https://www.worldkidneyday.org/facts/chronic-kidney-disease
PROF. STEPHAN JACOB
Dr. Jacob is an Endocrinologist, Diabetologist, Nutrition Expert and Clinical Hypertension Specialist in Private Practice.
DR. HELMUT BRATH
DR. KRISTIAN JONG HØINES
Specialist General Practitioner in Tananger and Assistant Professor at the Department of Global Public Health and Primary Care at the University of Bergen.
PROF. GOTTFRIED RUDOFSKY
Specialist in Internal Medicine – Endocrinology and Diabetology, Nephrology. Head of private practice in the fields of internal medicine and endocrinology, Olten, Switzerland.
PROF. PETER ROSSING
Head of department for Complications Research at Steno Diabetes Center Copenhagen, and Professor in Endocrinology at Department of Clinical Medicine, University of Copenhagen.
PROF. TROND JENSSEN
Professor of Nephrology in the Department of Clinical Medicine, University of Oslo, and leader of the Research Group for Transplantation Medicine, Section of Nephrology, Rikshospitalet, Oslo University Hospital.
As opiniões e opiniões apresentadas são apenas dos autores. O conteúdo deste webcast destina-se apenas a fins informativos/educativos.
© 2023 Abbott. Todos os direitos reservados. Todas as marcas comerciais mencionadas são marcas comerciais do grupo de empresas Abbott ou de seus respectivos proprietários. COL-16422 01/2023